What Are Cataracts in Dogs: Causes, Signs & Treatment

Cataracts in dogs are opacities that develop inside the lens of the eye, progressively clouding what should be a perfectly transparent structure and eventually blocking light from reaching the retina. They are one of the most common causes of blindness in dogs, and unlike the normal age-related haziness many owners notice (called nuclear sclerosis, which rarely affects vision), true cataracts can advance to the point where a dog loses functional sight entirely. The causes range from inherited genetic mutations to diabetes, and the only proven cure is surgery, though the landscape around that core answer has more nuance than most owners expect.

What Happens Inside the Lens

The lens of a mammalian eye is made almost entirely of tightly organized crystallin proteins. These proteins are packed in a precise arrangement that keeps the lens clear and allows it to focus light. When that arrangement breaks down for any reason, the exposed protein surfaces clump together into aggregates, scattering light instead of transmitting it. That clumping is the cataract. The process is fundamentally the same in dogs and humans: once the crystallin structure is disrupted, the cloudy patches grow as more protein aggregates accumulate.

Why Dogs Develop Cataracts

Most cataracts in dogs fall into a handful of categories, and hereditary cataracts are by far the most common type. Genetics account for the majority of cases seen by veterinary ophthalmologists, and dozens of breeds carry known predispositions. Diabetes is the second major cause, and diabetic cataracts tend to develop with alarming speed. Beyond those two, cataracts can also arise from eye trauma (both blunt and penetrating injuries), radiation exposure, congenital defects present at birth, age-related changes in older dogs, and as a secondary consequence of other eye diseases like chronic uveitis or retinal degeneration.

A study tracking progression across these different causes found that the rate at which cataracts worsened varied considerably. Diabetic and congenital cataracts both progressed in about two-thirds of cases, while age-related (senile) cataracts progressed in roughly 30% of cases, and cataracts caused by radiation exposure showed no progression at all during the study period.¹ That variability matters for you as an owner, because it means the timeline from diagnosis to potential blindness depends heavily on the underlying cause.

Diabetic Cataracts and the Sorbitol Problem

Diabetic cataracts deserve special attention because they can appear almost overnight. When blood sugar is chronically high, glucose floods into the lens. Normally the lens handles glucose through its usual metabolic pathways, but when those pathways are overwhelmed, an alternate enzyme kicks in and converts the excess glucose into sorbitol. Sorbitol draws water into the lens through osmotic pressure, and the resulting swelling disrupts the delicate protein structure rapidly.² Many owners of newly diagnosed diabetic dogs report their pet’s eyes going cloudy within weeks or even days of the first symptoms of diabetes. This is not a gradual fading; it can be sudden and bilateral.

The Genetic Side

Hereditary cataracts in dogs involve multiple genes, and researchers have pinpointed specific mutations in certain breeds. Mutations in the HSF4 gene have been identified in Staffordshire Bull Terriers, Boston Terriers, and Australian Shepherds. Interestingly, the same gene can behave differently across breeds: the mutations cause a recessive form of cataract in Staffordshire Bull Terriers and Boston Terriers but a dominant form in Australian Shepherds, meaning Australian Shepherds need only one copy of the faulty gene to be affected.³

More recently, researchers identified a separate genetic locus involving the CPT1A gene that is strongly associated with cataracts in several northern breeds, including the Siberian Husky, Samoyed, Icelandic Sheepdog, and Norwegian Buhund. These dogs tend to develop bilateral posterior polar subcapsular cataracts, a specific type that forms at the back surface of the lens.⁴ This discovery was significant because CPT1A had not previously been linked to cataracts, suggesting that the genetic picture in dogs is still far from complete.

Stages and What You’ll Actually See

Veterinary ophthalmologists classify cataracts into stages based on how much of the lens is affected and how much vision remains. Understanding these stages helps because they directly influence treatment decisions and prognosis.

Incipient: The earliest stage, where the opacity covers a small portion of the lens. Your dog’s vision is still functional, and you may not notice anything at home. A veterinarian using a slit lamp can see the early clouding.
Immature: The opacity has grown to involve more of the lens but is not yet complete. Vision is reduced, and your dog may start bumping into objects in dim light or unfamiliar spaces.
Mature: The entire lens is opaque. The dog has lost functional vision in that eye. You can often see the white, milky appearance of the lens just by looking at your dog.
Intumescent: The lens has become swollen with fluid, pushing against the structures around it and decreasing the space in the front chamber of the eye. This stage carries a higher risk of complications like glaucoma.
Hypermature: The lens proteins have begun to break down and reabsorb. The capsule surface becomes wrinkled and irregular. Some dogs at this stage appear to regain partial light perception as the lens thins, but the inflammation caused by leaking proteins creates its own serious problems.

These stages are assessed through slit-lamp examination, ultrasound of the eye, and clinical tests for vision like the menace response, where the examiner moves a hand quickly toward the eye to see if the dog blinks.⁵ By the mature stage, dogs typically fail the menace response entirely.

Diagnosing Cataracts and Evaluating the Eye

Confirming the presence and stage of a cataract is usually straightforward for a veterinary ophthalmologist, but the real diagnostic work is figuring out whether the rest of the eye is healthy enough to benefit from surgery. A cataract blocks the examiner’s view of the retina, so additional tests are needed to assess what’s going on behind the cloudy lens.

Electroretinography measures the electrical activity of the retina in response to light flashes. It is routinely performed before cataract surgery to confirm that the retina is still capable of processing visual information.⁶ If the retina has degenerated, removing the cataract will not restore sight. Ocular ultrasound provides a structural view behind the opaque lens, allowing the ophthalmologist to check for retinal detachment, tumors, or other abnormalities that would change the surgical plan.⁷ Together, these tests help determine whether a dog is a good surgical candidate.

Phacoemulsification: The Standard Surgery

The gold standard treatment for cataracts in dogs is phacoemulsification, the same basic technique used in human cataract surgery. An ultrasonic probe is inserted through a small incision in the cornea, breaks the cloudy lens material into tiny fragments, and suctions them out. An artificial intraocular lens is then folded, inserted through the same small incision, and positioned inside the now-empty lens capsule. The entire procedure is typically done through an incision of about 3 millimeters.⁸

Success rates are high. One retrospective study reported that functional vision was restored in 96% of eyes after phacoemulsification.⁹ In a longer-term comparison study with a median follow-up of over two years, surgically treated eyes vastly outperformed both medically treated and untreated eyes. Untreated eyes all eventually failed, and the rate of failure was roughly 255 times higher in untreated eyes than in surgically treated ones. Even medically managed eyes (treated with anti-inflammatory drops but no surgery) had a failure rate about four times higher than eyes that received surgery.¹⁰

Timing matters. Across all treatment approaches, the success rate for mature and hypermature cataracts was lower than for immature cataracts.¹⁰ Waiting until the cataract is fully mature before seeking referral reduces the odds of a good outcome, which is why veterinary ophthalmologists generally recommend surgery sooner rather than later once cataracts are progressing.

When Surgery Isn’t an Option

Not every dog is a candidate for phacoemulsification. Some have concurrent retinal disease that means surgery would not restore vision. Others have systemic health problems that make general anesthesia risky, or their owners face financial constraints. In these situations, medical management focuses on controlling the inflammation that cataracts cause rather than removing the cataract itself.

Topical anti-inflammatory eye drops, usually a combination of a corticosteroid or nonsteroidal anti-inflammatory drug, are the mainstay. They do not reverse or halt the cataract, but they reduce the lens-induced uveitis that accompanies protein leakage from the damaged lens. Even with this limitation, medically managed eyes did significantly better than completely untreated eyes in comparative studies.¹⁰ If your dog cannot have surgery, getting a prescription for ongoing anti-inflammatory drops is still worth pursuing to protect the eye from secondary damage.

What Happens If You Do Nothing

Left completely untreated, cataracts do not just cause blindness. They trigger a cascade of inflammation inside the eye. As lens proteins leak through or are released from a deteriorating lens capsule, the immune system reacts to them as foreign material. This causes lens-induced uveitis, a chronic inflammation of the interior of the eye that can lead to glaucoma (dangerously elevated eye pressure), retinal detachment, and chronic pain.

When the lens capsule actually ruptures, a more severe reaction called phacoclastic uveitis develops. In a study of 20 dogs with lens capsule rupture, the resulting inflammation did not respond to medical therapy and ultimately led to the loss of the affected eye in every case. The reaction was dominated by proliferation of lens cells, blockage of the pupil, and secondary glaucoma.¹¹ The milder version, phacolytic uveitis, occurs when protein leaks through an intact but deteriorating capsule of a hypermature cataract. It is more manageable but still a persistent source of discomfort and progressive damage.

This is the reason veterinary ophthalmologists push for early referral. The “wait and see” approach that feels instinctively cautious can actually put the eye at greater risk.

Anesthesia Risks for Diabetic Dogs

Because diabetes is one of the leading causes of cataracts in dogs, a large proportion of cataract surgery patients are diabetic, and this introduces specific anesthetic concerns. A retrospective comparison found that diabetic dogs undergoing phacoemulsification were more likely to develop moderate and severe drops in blood pressure during anesthesia than non-diabetic dogs. About 44% of the diabetic dogs in the study experienced at least one episode of severe high blood sugar while under anesthesia, and the resulting osmotic diuresis (where the kidneys flush excess fluid) likely contributed to the blood pressure problems.¹²

These complications are manageable with proper monitoring and preparation, but they underscore the importance of having cataract surgery performed at a facility experienced with diabetic patients. Your veterinary ophthalmologist and anesthesiologist will typically work together to manage insulin dosing, fluid therapy, and blood-pressure support throughout the procedure.

Can Antioxidants Slow Progression?

For senile (age-related) cataracts that progress slowly, some owners wonder whether nutritional supplements can delay the inevitable. A retrospective study compared dogs with senile cataracts that received oral antioxidant supplements to those that did not. The supplemented group showed a significantly lower rate of cataract progression, with the risk of worsening reduced by roughly 75% compared to the control group.¹³ This is encouraging, but it was a retrospective study, which means the evidence is not as strong as it would be from a randomized controlled trial. Dogs in the supplement group may have differed from the control group in ways that weren’t captured.

Still, the finding is consistent with what we know about oxidative stress in lens aging, and oral antioxidant supplements are generally low-risk. They are unlikely to reverse existing cataracts, but for dogs with early-stage senile cataracts where surgery is not yet warranted, they may be a reasonable discussion to have with your veterinarian.

Lanosterol and the Hope for Eye Drops

One of the most widely discussed potential breakthroughs in cataract research has been lanosterol, a naturally occurring steroid that plays a role in maintaining crystallin protein solubility. In laboratory and animal studies, lanosterol showed the ability to partially dissolve existing lens opacities by helping aggregated proteins re-fold into their proper, transparent arrangement.¹⁴

Subsequent research in primates has added nuance. A study using a sustained-release injection system to deliver lanosterol near the eye found that cortical cataracts (those forming in the outer layers of the lens) showed measurable improvement, particularly in the first two weeks. However, nuclear cataracts (those in the dense center of the lens) showed almost no response.¹⁵ The cortical cataracts also began to re-opacify after the drug effect waned, suggesting that any future lanosterol-based treatment would need to be sustained rather than one-time.

There is no lanosterol eye drop currently approved for veterinary or human use. Products marketed online as “cataract drops” for dogs do not contain lanosterol in a formulation that has been shown to work in clinical trials. The research is genuinely promising for certain types of cataracts, but it has not yet translated into a product you can buy and use at home.

Breed Screening and Prevention

Given how prevalent hereditary cataracts are, prevention largely depends on responsible breeding practices. In many countries, breeding dogs of at-risk breeds undergo regular eye examinations by board-certified veterinary ophthalmologists, and the results are recorded in registries. In the United States, the Companion Animal Eye Registry (formerly CERF) is maintained by the American College of Veterinary Ophthalmologists and provides a framework for certifying that breeding dogs are free of heritable eye diseases.¹⁶ Similar screening programs operate in Europe and elsewhere.

DNA tests are now available for some of the known cataract-causing mutations, including the HSF4 mutations found in Boston Terriers, Staffordshire Bull Terriers, and Australian Shepherds. Breeders can test parent dogs and make informed mating decisions to reduce the chances of producing affected puppies. For breeds where the exact genetic mutation has not yet been identified, regular clinical eye exams remain the primary screening tool.¹⁷

If you are purchasing a puppy from a breed known to be at risk, asking the breeder for documentation of eye screening on the parents is one of the most practical steps you can take. It does not eliminate risk entirely, since new mutations can arise and not all cataract genes have been identified, but it meaningfully reduces it.

How Vision Loss Affects a Dog’s Daily Life

Owners sometimes wonder whether a blind or visually impaired dog can still enjoy a good quality of life. Many dogs adapt remarkably well to vision loss, relying on their other senses to navigate familiar environments. However, research using validated scoring tools has shown that the degree of vision impairment does correlate with a dog’s overall health-related quality of life: dogs with greater functional vision loss score lower on quality-of-life assessments than dogs with milder impairment.¹⁸

Practically, dogs with progressing cataracts tend to become more hesitant in unfamiliar settings, may startle more easily when approached from the affected side, and sometimes become less willing to navigate stairs or jump onto furniture. These behavioral changes are often the first thing owners notice before they realize the cloudiness in their dog’s eyes is more than a normal aging change. Keeping furniture in consistent locations, using verbal cues before physical contact, and adding textured mats near stairways can make a meaningful difference for dogs living with partial or complete vision loss.

1
PubMed. Progression and complications of canine cataracts for different stages of development and aetiologies
2
PubMed Central. Effect of Oral Alpha Lipoic Acid in Preventing the Genesis of Canine Diabetic Cataract: A Preliminary Study
3
PubMed. Identification of mutations in HSF4 in dogs of three different breeds with hereditary cataracts
4
PLoS ONE. Common variants in the CPT1A gene are associated with cataracts in Northern breeds of domestic dog
5
Pesquisa Veterinária Brasileira. Accuracy of ARFI elastography in the differentiation of cataract stages in dogs
6
PubMed. Retrospective evaluation of pre-surgical electroretinography results in a mixed-breed canine population presented for cataract removal surgery
7
Pesquisa Veterinária Brasileira. A and B mode ultrasonography in preoperative evaluation of lens and posterior segment of dogs eyes with cataract
8
PubMed Central. Phacoemulsification and acryl foldable intraocular lens implantation in dogs: 32 cases
9
The Thai Journal of Veterinary Medicine. Success Rate and Postoperative Complications of Phacoemulsification in 25 Cataractous Eyes: a Retrospective Study in 20 Dogs (2003-2005)
10
PubMed Central. Cataracts in 44 dogs (77 eyes): A comparison of outcomes for no treatment, topical medical management, or phacoemulsification with intraocular lens implantation
11
PubMed. The pathology of lens-induced uveitis in dogs
12
PubMed. A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study
13
PubMed Central. Effect of oral antioxidants on the progression of canine senile cataracts: a retrospective study
14
Nature. Lanosterol reverses protein aggregation in cataracts
15
PubMed Central. Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system
16
PubMed Central. Ophthalmic Disease and Screening in Breeding Dogs
17
PubMed. Cataracts in the Norwegian Buhund-current prevalence and characteristics
18
PubMed. Development of a vision impairment score for the assessment of functional vision in dogs: Initial evidence of validity, reliability, and responsiveness